A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc.
Istituto Oncologico Veneto IRCCS
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Fudan University
Sunnybrook Health Sciences Centre
University Medical Center Groningen
Region of Southern Denmark
Sun Yat-sen University
Massachusetts General Hospital
Centre Georges Francois Leclerc
Jiangsu Hansoh Pharmaceutical Co., Ltd.
RenJi Hospital
Institut Mutualiste Montsouris
Chongqing Precision Biotech Co., Ltd
Chongqing Precision Biotech Co., Ltd
Chongqing Precision Biotech Co., Ltd
Infinity Pharmaceuticals, Inc.
Peking Union Medical College Hospital
The Affiliated Hospital of Qingdao University
Peking Union Medical College Hospital
Peking Union Medical College Hospital
Peking Union Medical College Hospital
Western Sydney Local Health District
Betta Pharmaceuticals Co., Ltd.
Assistance Publique - Hôpitaux de Paris
RenJi Hospital
Rutgers, The State University of New Jersey
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Jules Bordet Institute
Institut Bergonié
Chinese University of Hong Kong
Zhejiang Cancer Hospital
Affiliated Hospital of Jiangnan University
Institut de cancérologie Strasbourg Europe
Trans Tasman Radiation Oncology Group
University of Leeds
University College, London
RenJi Hospital
Sohag University
Jiangsu HengRui Medicine Co., Ltd.
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Weprom
Hospices Civils de Lyon
Sunnybrook Health Sciences Centre
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
TScan Therapeutics, Inc.
Peking Union Medical College Hospital
St. Joseph's Healthcare Hamilton
Centre Hospitalier Universitaire de Besancon